Table 4.
Meta-analysis of laboratory findings.
| Pooled frequency | n/N* | Publication bias | Heterogeneity test | ||
|---|---|---|---|---|---|
| (95% CI) | (p-value) | I2 (%) | p-value | ||
| Lymphopenia | 50.1 (38.0–62.4) | 1,122/1,853 | 0.08 | 93 | 0.00 |
| Lymphocytosis | 33.5 (2.4–90.2) | 55/93 | NA | 88 | 0.00 |
| Neutrophilia | 29.7 (19.3–42.7) | 60/191 | 0.51 | 58.7 | 0.08 |
| Leukopenia | 28.0 (20.0–37.4) | 544/1,798 | 0.89 | 88 | 0.00 |
| Leukocytosis | 10.8 (5.8–19.1) | 165/1,829 | 0.86 | 92 | 0.00 |
| Thrombocytopenia | 11.1 (7.7–15.7) | 343/1,393 | 0.00 | 86 | 0.00 |
| Anemia | 43.5 (30.3–57.7) | 79/179 | NA | 72 | 0.00 |
| Decreased albumin | 51.8 (2.0–98.0) | 105/191 | 0.99 | 96 | 0.00 |
| High CRP | 72.0 (54.3–84.6) | 918/1,681 | 0.02 | 96 | 0.00 |
| High LDH | 41.0 (22.8–62.0) | 408/1,393 | 0.32 | 94 | 0.00 |
| High ESR | 79.7 (66.6–88.5) | 143/179 | NA | 69 | 0.00 |
| High AST | 19.7 (10.5–33.7) | 267/1,474 | 0.70 | 93 | 0.00 |
| High ALT | 14.6 (7.6–26.3) | 191/1,290 | 0.99 | 84.8 | 0.00 |
| High creatinine kinase | 14.1 (8.3–23.0) | 142/1,453 | 0.20 | 84 | 0.00 |
| High bilirubin | 7.9 (2.9–19.0) | 95/1,278 | 0.96 | 89 | 0.00 |
| High creatinine | 3.3 (1.2–9.1) | 20/1,294 | 0.13 | 74 | 0.00 |
| High troponin I | 2.4 (0.3–15.0) | 1/41 | NA | 0.00 | 0.1 |